BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 16094219)

  • 21. Reduction of catheter-related infections in neutropenic patients: a prospective controlled randomized trial using a chlorhexidine and silver sulfadiazine-impregnated central venous catheter.
    Jaeger K; Zenz S; Jüttner B; Ruschulte H; Kuse E; Heine J; Piepenbrock S; Ganser A; Karthaus M
    Ann Hematol; 2005 Apr; 84(4):258-62. PubMed ID: 15549302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.
    Darouiche RO; Raad II; Heard SO; Thornby JI; Wenker OC; Gabrielli A; Berg J; Khardori N; Hanna H; Hachem R; Harris RL; Mayhall G
    N Engl J Med; 1999 Jan; 340(1):1-8. PubMed ID: 9878638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting zero catheter-related bloodstream infections in pediatric intensive care unit: a retrospective matched case-control study.
    Biasucci DG; Pittiruti M; Taddei A; Picconi E; Pizza A; Celentano D; Piastra M; Scoppettuolo G; Conti G
    J Vasc Access; 2018 Mar; 19(2):119-124. PubMed ID: 29148002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chlorhexidine-impregnated dressing for prevention of catheter-related bloodstream infection: a meta-analysis*.
    Safdar N; O'Horo JC; Ghufran A; Bearden A; Didier ME; Chateau D; Maki DG
    Crit Care Med; 2014 Jul; 42(7):1703-13. PubMed ID: 24674924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand.
    Balamongkhon B; Thamlikitkul V
    Am J Infect Control; 2007 Nov; 35(9):585-8. PubMed ID: 17980236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of chlorhexidine/silver sulfadiazine-impregnated central venous catheters in an intensive care unit with a low blood stream infection rate after implementation of an educational program: a before-after trial.
    Schuerer DJ; Zack JE; Thomas J; Borecki IB; Sona CS; Schallom ME; Venker M; Nemeth JL; Ward MR; Verjan L; Warren DK; Fraser VJ; Mazuski JE; Boyle WA; Buchman TG; Coopersmith CM
    Surg Infect (Larchmt); 2007 Aug; 8(4):445-54. PubMed ID: 17883361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreasing catheter colonization through the use of an antiseptic-impregnated catheter: a continuous quality improvement project.
    Collin GR
    Chest; 1999 Jun; 115(6):1632-40. PubMed ID: 10378561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis.
    Veenstra DL; Saint S; Saha S; Lumley T; Sullivan SD
    JAMA; 1999 Jan; 281(3):261-7. PubMed ID: 9918482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chlorhexidine 2% and choice of transparent dressing increase skin reactions at central venous catheter insertion sites.
    Loewenthal M; Dobson P; Boyle M
    Am J Infect Control; 2016 Dec; 44(12):1712-1714. PubMed ID: 27544790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of a second-generation venous catheter impregnated with chlorhexidine and silver sulfadiazine on central catheter-related infections: a randomized, controlled trial.
    Rupp ME; Lisco SJ; Lipsett PA; Perl TM; Keating K; Civetta JM; Mermel LA; Lee D; Dellinger EP; Donahoe M; Giles D; Pfaller MA; Maki DG; Sherertz R
    Ann Intern Med; 2005 Oct; 143(8):570-80. PubMed ID: 16230723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorhexidine-impregnated gel dressing compared with transparent polyurethane dressing in the prevention of catheter-related infections in critically ill adult patients: A pilot randomised controlled trial.
    Margatho AS; Ciol MA; Hoffman JM; Dos Reis PED; Furuya RK; Lima DAFS; Basile-Filho A; Silveira RCCP
    Aust Crit Care; 2019 Nov; 32(6):471-478. PubMed ID: 30558968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chlorhexidine-impregnated dressing for the prophylaxis of central venous catheter-related complications: a systematic review and meta-analysis.
    Wei L; Li Y; Li X; Bian L; Wen Z; Li M
    BMC Infect Dis; 2019 May; 19(1):429. PubMed ID: 31096918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluating central venous catheter care in a pediatric intensive care unit.
    Hatler C; Buckwald L; Salas-Allison Z; Murphy-Taylor C
    Am J Crit Care; 2009 Nov; 18(6):514-20; quiz 521. PubMed ID: 19880953
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
    Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
    J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective randomized trial of an antibiotic- and antiseptic-coated central venous catheter in the prevention of catheter-related infections.
    Tennenberg S; Lieser M; McCurdy B; Boomer G; Howington E; Newman C; Wolf I
    Arch Surg; 1997 Dec; 132(12):1348-51. PubMed ID: 9403542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
    Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
    J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
    Maunoury F; Motrunich A; Palka-Santini M; Bernatchez SF; Ruckly S; Timsit JF
    PLoS One; 2015; 10(6):e0130439. PubMed ID: 26086783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlorhexidine gluconate transparent dressing does not decrease central line-associated bloodstream infection in critically ill patients: A randomized controlled trial.
    Yu K; Lu M; Meng Y; Zhao Y; Li Z
    Int J Nurs Pract; 2019 Dec; 25(6):e12776. PubMed ID: 31631496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tegaderm™ CHG dressing significantly improves catheter-related infection rate in hemodialysis patients.
    Righetti M; Palmieri N; Bracchi O; Prencipe M; Bruschetta E; Colombo F; Brenna I; Stefani F; Amar K; Scalia A; Conte F
    J Vasc Access; 2016 Sep; 17(5):417-422. PubMed ID: 27516139
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chlorhexidine-impregnated sponge versus chlorhexidine gel dressing for short-term intravascular catheters: which one is better?
    Buetti N; Ruckly S; Schwebel C; Mimoz O; Souweine B; Lucet JC; Timsit JF
    Crit Care; 2020 Jul; 24(1):458. PubMed ID: 32703235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.